Featured Articles : Menopause

Editor's Picks

Hormone therapy for sexual function in perimenopausal and postmenopausal women: a systematic review and meta-analysis update

Meziou, Nadia; Scholfield, Clare; Taylor, Caroline A.; More

Menopause. 30(6):659-671, June 2023.

Open
SDC

Early menopause and cardiovascular risk factors: a cross-sectional and longitudinal study

Roa-Díaz, Zayne Milena; Wehrli, Faina; Lambrinoudaki, Irene; More

Menopause. 30(6):599-606, June 2023.

Open
SDC

Association of hormone preparations with bone mineral density, osteopenia, and osteoporosis in postmenopausal women: data from National Health and Nutrition Examination Survey 1999-2018

Wang, Yiran; Sun, Chao

Menopause. 30(6):591-598, June 2023.

Open

Natural history and malignant potential of simple ovarian cysts in postmenopausal women: a systematic review and meta-analysis

Liu, Ya-Na; Tan, Xin; Xiong, Wei; More

Menopause. 30(5):559-565, May 2023.

Treating where it hurts—a randomized comparative trial of vestibule estradiol for postmenopausal dyspareunia

Goetsch, Martha F.; Garg, Bharti; Lillemon, Jen; More

Menopause. 30(5):467-475, May 2023.

Lifetime history of interpersonal partner violence is associated with insomnia among midlife women veterans

Goldstein, Lizabeth A.; Jakubowski, Karen P.; Huang, Alison J.; More

Menopause. 30(4):370-375, April 2023.

Effect of ospemifene on vaginal microbiome in postmenopausal women with vulvovaginal atrophy

Alvisi, Stefania; Ceccarani, Camilla; Foschi, Claudio; More

Menopause. 30(4):361-369, April 2023.

Antimüllerian hormone and adiposity across midlife among women in Project Viva

Francis, Ellen C.; Oken, Emily; Hivert, Marie-France; More

Menopause. 30(3):247-253, March 2023.

Efficacy and safety of elinzanetant, a selective neurokinin-1,3 receptor antagonist for vasomotor symptoms: a dose-finding clinical trial (SWITCH-1)

Simon, James A.; Anderson, Richard A.; Ballantyne, Elizabeth; More

Menopause. 30(3):239-246, March 2023.

Open
SDC

Physical activity and exercise for hot flashes: trigger or treatment?

Witkowski, Sarah; Evard, Rose; Rickson, Jacquelyn J.; More

Menopause. 30(2):218-224, February 2023.

Loss of muscle mass in women with premature ovarian insufficiency as compared with healthy controls

Li, Saisai; Ma, Linjuan; Huang, Haiying; More

Menopause. 30(2):122-127, February 2023.

Relationship between handgrip strength and endogenous hormones in postmenopausal women

García-Alfaro, Pascual; García, Sandra; Rodriguez, Ignacio; More

Menopause. 30(1):11-17, January 2023.

Estimation of placebo effect in randomized placebo-controlled trials for moderate or severe vasomotor symptoms: a meta-analysis

Zhou, Tianyu

Menopause. 30(1):5-10, January 2023.

The severity of individual menopausal symptoms, cardiovascular disease, and all-cause mortality in the Women's Health Initiative Observational Cohort

Nudy, Matthew; Aragaki, Aaron K.; Jiang, Xuezhi; More

Menopause. 29(12):1365-1374, December 2022.

Menopause hormone therapy and complementary alternative medicine, quality of life, and racial/ethnic differences: the Study of Women's Health Across the Nation (SWAN)

Christmas, Monica; Janssen, Imke; Joffe, Hadine; More

Menopause. 29(12):1357-1364, December 2022.

A human rights assessment of menopausal women's access to age- and gender-sensitive nondiscriminatory health care in prison

Van Hout, Marie-Claire; Srisuwan, Lizz; Plugge, Emma

Menopause. 29(11):1338-1348, November 2022.

A review of African American women's experiences in menopause

Williams, Makeba; Richard-Davis, Gloria; Weickert, Artemis; More

Menopause. 29(11):1331-1337, November 2022.

Climacteric status is associated with sexual dysfunction at the age of 46 years: a population-based study

Savukoski, Susanna M.; Pinola, Pekka A.; Pesonen, Paula R. O.; More

Menopause. 29(11):1239-1246, November 2022.

Association between lower parity and low muscle mass in postmenopausal women: data from KNHANES (2010-2011)

Ahn, So Hyun; Kim, Heeyon; In Kim, Hye; More

Menopause. 29(10):1137-1144, October 2022.

Self-reported menstrual cycle length during reproductive years in relation to menopausal symptoms at midlife in Project Viva

Mínguez-Alarcón, Lidia; Rifas-Shiman, Sheryl L.; Soria-Contreras, Diana C.; More

Menopause. 29(10):1130-1136, October 2022.

Perception of higher frequency of daily hot flashes in 50-year-old women today: a study of trends over time during 48 years in the Population Study of Women in Gothenburg, Sweden

Rödström, Kerstin; Weman, Lilian; Sundh, Valter; More

Menopause. 29(10):1124-1129, October 2022.

Health screening of middle-aged women: what factors impact longevity?

Blümel, Juan E.; Aedo, Sócrates; Murray, Nigel; More

Menopause. 29(9):1008-1013, September 2022.

Estrogen therapy and breast cancer in randomized clinical trials: a narrative review

Pan, Kathy; Lavasani, Sayeh; Aragaki, Aaron K.; More

Menopause. 29(9):1086-1092, September 2022.

Uterine arcuate artery calcification as a potential marker of cardiovascular risk—a preliminary study

Akilli, Rabia; Kucukgoz Gulec, Umran; Deniz, Ali; More

Menopause. 29(8):905-910, August 2022.

The longitudinal relation of inflammation to incidence of vasomotor symptoms

Gold, Ellen B.; Xing, Guibo; Avis, Nancy E.; More

Menopause. 29(8):894-904, August 2022.

Childhood maltreatment and the menopause transition in a cohort of midlife New Zealand women

Cleland, Lana; McLeod, Geraldine F.H.; Dhakal, Bhubaneswor; More

Menopause. 29(7):816-822, July 2022.

Risk of high depressive symptoms after the final menstrual period: the Study of Women’s Health Across the Nation (SWAN)

Kravitz, Howard M.; Colvin, Alicia B.; Avis, Nancy E.; More

Menopause. 29(7):805-815, July 2022.

The association between shift work exposure and the variations in age at natural menopause among adult Canadian workers: results from the Canadian Longitudinal Study on Aging (CLSA)

Khan, Durdana; Rotondi, Michael; Edgell, Heather; More

Menopause. 29(7):795-804, July 2022.

Clinical suspicion of sarcopenic obesity and probable sarcopenic obesity in Colombian women with a history of surgical menopause: a cross-sectional study

Monterrosa-Castro, Álvaro; Prada-Tobar, María; Monterrosa-Blanco, Angélica; More

Menopause. 29(6):664-670, June 2022.

Female orgasmic dysfunction and severe climacteric symptomatology in women aged 40 to 59 years: an independent association from an analysis of a multicenter Latin American study

Urrunaga-Pastor, Diego; Mezones-Holguin, Edward; Blümel, Juan E.; More

Menopause. 29(6):654-663, June 2022.

Where does postmenopausal dyspareunia hurt? A cross-sectional report

Goetsch, Martha F.; Garg, Bharti; Lillemon, Jen; More

Menopause. 29(6):646-653, June 2022.

Oophorectomy and rate of dementia: a prospective cohort study

Uldbjerg, Cecilie S.; Wilson, Louise F.; Koch, Trine; More

Menopause. 29(5):514-522, May 2022.

Avoidable bilateral salpingo-oophorectomy at hysterectomy: a large retrospective study

Iancu, Ana-Maria; Murji, Ally; Chow, Ovina; More

Menopause. 29(5):523-530, May 2022.

Metabolic effects of menopause: a cross-sectional characterization of body composition and exercise metabolism

Gould, Lacey M.; Gordon, Amanda N.; Cabre, Hannah E.; More

Menopause. 29(4):377-389, April 2022.

Translabial ultrasound indices of failed pessary fittings in women with symptomatic pelvic organ prolapse

Xu, Hainan; Wu, Wenjing; Wang, Xinlu; More

Menopause. 29(4):390-396, April 2022.

Open
SDC

Association of sleep disturbance with Parkinson disease: evidence from the Women's Health Initiative

Beydoun, Hind A.; Naughton, Michelle J.; Beydoun, May A.; More

Menopause. 29(3):255-263, March 2022.

Duodenal microbiome changes in postmenopausal women: effects of hormone therapy and implications for cardiovascular risk

Leite, Gabriela; Barlow, Gillian M.; Parodi, Gonzalo; More

Menopause. 29(3):264-275, March 2022.

Open
SDC

Clinicopathologic characteristics and risk factors for endometrial malignancy in postmenopausal women with endometrial thickening

Ai, Fangfang; Wang, Yiling; Zhou, Liane; More

Menopause. 29(2):137-143, February 2022.

Prevalence and factors associated with overactive bladder and stress urinary incontinence in the Japan Nurses’ Health Study

Nagai, Kazue; Homma, Yukio; Ideno, Yuki; More

Menopause. 29(2):129-136, February 2022.

Patterns of menstrual cycle length over the menopause transition are associated with subclinical atherosclerosis after menopause

El Khoudary, Samar R.; Qi, Meiyuzhen; Chen, Xirun; More

Menopause. 29(1):8-15, January 2022.

Handgrip strength, dynapenia, and related factors in postmenopausal women

García-Alfaro, Pascual; García, Sandra; Rodríguez, Ignacio; More

Menopause. 29(1):16-22, January 2022.

Treatment of menopausal symptoms: concomitant modification of cortisol

Cagnacci, Angelo; Xholli, Anjeza; Fontanesi, Francesca; More

Menopause. 29(1):23-27, January 2022.

Free

Dietary syringic acid reduces fat mass in an ovariectomy-induced mouse model of obesity

Tanaka, Teruyoshi; Iwamoto, Kazuko; Wada, Maki; More

Menopause. 28(12):1340-1350, December 2021.

Hand grip strength and health-related quality of life in postmenopausal women: a national population-based study

Hong, Yun Soo; Kim, Hoon

Menopause. 28(12):1330-1339, December 2021.

Growth of surgically confirmed leiomyomas in postmenopausal women: analysis of the influencing factors

Shen, Minghong; Duan, Hua; Chang, Yanan; More

Menopause. 28(11):1209-1213, November 2021.

Menopausal hormone therapy and risk of incident hypertension: role of the route of estrogen administration and progestogens in the E3N cohort

Madika, Anne-Laure; MacDonald, Conor James; Fournier, Agnès; More

Menopause. 28(11):1204-1208, November 2021.

Reproductive period and preclinical cerebrospinal fluid markers for Alzheimer disease: a 25-year study

Najar, Jenna; Hällström, Tore; Zettergren, Anna; More

Menopause. 28(10):1099-1107, October 2021.

Open
SDC

Obesity increases endometrial cancer risk in Chinese women with postmenopausal bleeding

Liu, Fangzi; Cheung, Eva C.W.; Lao, Terence T.

Menopause. 28(10):1093-1098, October 2021.

Impact of menopausal status on risk of metastatic recurrence of breast cancer

Lao, Chunhuan; Elwood, Mark; Kuper-Hommel, Marion; More

Menopause. 28(10):1085-1092, October 2021.

The role of multiparity and maternal age at first pregnancy in the association between early menarche and metabolic syndrome among middle-aged and older women

Rocha, Tiago Novais; Macêdo, Pedro Rafael de Souza; Vafaei, Afshin; More

Menopause. 28(9):1004-1011, September 2021.

Evaluation of endometrial progesterone receptor expression after 12 weeks of exposure to a low-dose vaginal estradiol insert

Mirkin, Sebastian; Simon, James A.; Liu, James H.; More

Menopause. 28(9):998-1003, September 2021.

Open

Global cross-sectional survey of women with vasomotor symptoms associated with menopause: prevalence and quality of life burden

Nappi, Rossella E.; Kroll, Robin; Siddiqui, Emad; More

Menopause. 28(8):875-882, August 2021.

Open
SDC

Safety assessment of compounded non-FDA-approved hormonal therapy versus FDA-approved hormonal therapy in treating postmenopausal women

Jiang, Xuezhi; Bossert, Anna; Parthasarathy, K. Nathan; More

Menopause. 28(8):867-874, August 2021.

A core outcome set for genitourinary symptoms associated with menopause: the COMMA (Core Outcomes in Menopause) global initiative

Lensen, Sarah; Bell, Robin J.; Carpenter, Janet S.; More

Menopause. 28(8):859-866, August 2021.

A core outcome set for vasomotor symptoms associated with menopause: the COMMA (Core Outcomes in Menopause) global initiative

Lensen, Sarah; Archer, David; Bell, Robin J.; More

Menopause. 28(8):852-858, August 2021.

Independent association of palpitation with vasomotor symptoms and anxiety in middle-aged women

Enomoto, Haruka; Terauchi, Masakazu; Odai, Tamami; More

Menopause. 28(7):741-747, July 2021.

Predictors of the age at which natural menopause occurs in women with type 1 diabetes: the Pittsburgh Epidemiology of Diabetes Complications (EDC) study

Yi, Yan; El Khoudary, Samar R.; Buchanich, Jeanine M.; More

Menopause. 28(7):735-740, July 2021.

Abdominal visceral adipose tissue over the menopause transition and carotid atherosclerosis: the SWAN heart study

Samargandy, Saad; Matthews, Karen A.; Brooks, Maria M.; More

Menopause. 28(6):626-633, June 2021.

Associations of sleep and female sexual function: good sleep quality matters

Kling, Juliana M.; Kapoor, Ekta; Mara, Kristin; More

Menopause. 28(6):619-625, June 2021.

Cardiovascular disease (CVD) risk scores, age, or years since menopause to predict cardiovascular disease in the Women's Health Initiative

Wild, Robert A.; Hovey, Kathleen M.; Andrews, Christopher; More

Menopause. 28(6):610-618, June 2021.

Hormone therapy as a possible solution for postmenopausal women with nocturia: results of a pilot trial

Pauwaert, Kim; Goessaert, An-Sofie; Ghijselings, Lynn; More

Menopause. 28(5):502-510, May 2021.

Menopausal status and observed differences in the gut microbiome in women with and without HIV infection

Peters, Brandilyn A.; Xue, Xiaonan; Wang, Zheng; More

Menopause. 28(5):491-501, May 2021.

Early and surgical menopause associated with higher Framingham Risk Scores for cardiovascular disease in the Canadian Longitudinal Study on Aging

Price, Madison A.; Alvarado, Beatriz E.; Rosendaal, Nicole T.A.; More

Menopause. 28(5):484-490, May 2021.

Open
SDC

Cognitive changes during the menopausal transition: a longitudinal study in women with and without HIV

Maki, Pauline M.; Springer, Gayle; Anastos, Kathryn; More

Menopause. 28(4):360-368, April 2021.

Short-term impact of surgically induced menopause on cognitive function and wellbeing in women at high risk for ovarian cancer following risk-reducing bilateral salpingo-oophorectomy

Chang, Heidi; Kamara, Daniella; Bresee, Catherine; More

Menopause. 28(4):354-359, April 2021.

Biopsychosocial predictors of depressive symptoms in the perimenopause—findings from the Swiss Perimenopause Study

Willi, Jasmine; Süss, Hannah; Grub, Jessica; More

Menopause. 28(3):247-254, March 2021.

High-density lipoprotein cholesterol and arterial calcification in midlife women: the contribution of estradiol and C-reactive protein

Swabe, Gretchen; Matthews, Karen; Brooks, Maria; More

Menopause. 28(3):237-246, March 2021.

Age-associated trends of vulvar cancer in the US

Khadraoui, Hanaa; Thappa, Sarah; Smith, Marianne; More

Menopause. 28(2):119-125, February 2021.

Does age at the start of treatment for vaginal atrophy predict response to vaginal estrogen therapy? Post hoc analysis of data from a randomized clinical trial involving 205 women treated with 10 μg estradiol vaginal tablets

Derzko, Christine M.; Röhrich, Sebastian; Panay, Nick

Menopause. 28(2):113-118, February 2021.

Age at menarche and cardiovascular health: results from the NHANES 1999-2016

Zheng, Yi; Wen, Tony S.; Shen, Yun; More

Menopause. 28(1):18-24, January 2021.

Prevalence and risk factors of morphometric vertebral fracture in apparently healthy osteopenic postmenopausal Thai women

Wattanachanya, Lalita; Pongchaiyakul, Chatlert

Menopause. 28(1):12-17, January 2021.

Unnecessary bilateral salpingo-oophorectomy at the time of hysterectomy and potential for ovarian preservation

Wong, Jellena; Murji, Ally; Sunderji, Zahra; More

Menopause. 28(1):8-11, January 2021.

Female reproductive health and cognitive function

Tsai, Chia-Kuang; Chen, Yuan-Yuei; Chou, Chung-Hsing; More

Menopause. 27(12):1357-1362, December 2020.

Effect of the neurokinin 3 receptor antagonist fezolinetant on patient-reported outcomes in postmenopausal women with vasomotor symptoms: results of a randomized, placebo-controlled, double-blind, dose-ranging study (VESTA)

Santoro, Nanette; Waldbaum, Arthur; Lederman, Samuel; More

Menopause. 27(12):1350-1356, December 2020.

Open
SDC

A selective serotonin receptor agonist for weight loss and management of menopausal vasomotor symptoms in overweight midlife women: a pilot study

Kapoor, Ekta; Faubion, Stephanie; Hurt, Ryan T.; More

Menopause. 27(11):1228-1235, November 2020.

Cognitive complaints are associated with smaller right medial temporal gray-matter volume in younger postmenopausal women

Conley, Alexander C.; Albert, Kimberly M.; Boyd, Brian D.; More

Menopause. 27(11):1220-1227, November 2020.

Physiologic vasomotor symptoms are associated with verbal memory dysfunction in breast cancer survivors

Fogel, Jessica; Rubin, Leah H.; Kilic, Ece; More

Menopause. 27(11):1209-1219, November 2020.

Bone mass in women with premature ovarian insufficiency: a comparative study between hormone therapy and combined oral contraceptives

Gazarra, Lívia B. Carvalho; Bonacordi, Camila L.; Yela, Daniela A.; More

Menopause. 27(10):1110-1116, October 2020.

Age at first childbirth in relation to oral health later in life

Lee, Seonah; Park, Sangshin

Menopause. 27(10):1104-1109, October 2020.

Association between waist-hip ratio and coronary artery calcification in postmenopausal women

Eun, Youngmi; Lee, Su Nam; Jung, Jin; More

Menopause. 27(9):1010-1014, September 2020.

Open

The effect of menopause on metabolic syndrome: cross-sectional results from the Canadian Longitudinal Study on Aging

Christakis, Marie K.; Hasan, Haroon; De Souza, Leanne R.; More

Menopause. 27(9):999-1009, September 2020.

Prevalence of ocular surface disease symptoms in peri- and postmenopausal women

Garcia-Alfaro, Pascual; Bergamaschi, Luciana; Marcos, Celia; More

Menopause. 27(9):993-998, September 2020.

Incidence of venous thromboembolism among postmenopausal women prescribed ospemifene, selective estrogen receptor modulators for noncancer indications, or untreated vulvar and vaginal atrophy

Nordstrom, Beth L.; Cai, Bin; De Gregorio, Fabio; More

Menopause. 27(8):864-871, August 2020.

Treatment for vaginal atrophy using microablative fractional CO₂ laser: a randomized double-blinded sham-controlled trial

Ruanphoo, Purim; Bunyavejchevin, Suvit

Menopause. 27(8):858-863, August 2020.

A multicenter, randomized study to select the minimum effective dose of estetrol (E4) in postmenopausal women (E4Relief): part 1. Vasomotor symptoms and overall safety

Gaspard, Ulysse; Taziaux, Mélanie; Mawet, Marie; More

Menopause. 27(8):848-857, August 2020.

Open
SDC

Depression, hormone therapy, and the menopausal transition among women aged 45 to 64 years using Canadian Longitudinal Study on aging baseline data

Shea, Alison K.; Sohel, Nazmul; Gilsing, Anne; More

Menopause. 27(7):763-770, July 2020.

Associations of social, physical, and financial factors with diet quality among older, community-dwelling women

Shikany, James M.; Manson, JoAnn E.; Shadyab, Aladdin H.; More

Menopause. 27(7):756-762, July 2020.

Executive function after risk-reducing salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: does current mood and early life adversity matter?

Shanmugan, Sheila; Sammel, Mary D.; Loughead, James; More

Menopause. 27(7):746-755, July 2020.

Knowledge and attitudes associated with menopause among women aged 45 to 60 years: a pilot study among rural and urban women in Bangladesh

Harun, Md. Golam Dostogir; Salema, Umme; Chowdhury, Aluddin; More

Menopause. 27(6):648-657, June 2020.

Featured Articles : Menopause

In Brief:

In Brief:

In Brief:

In Brief:

In Brief:

In Brief:

In Brief:

In Brief:

In Brief:

In Brief:

In Brief:

In Brief:

In Brief:

In Brief:

In Brief:

In Brief:

In Brief:

In Brief:

In Brief:

In Brief:

In Brief:

In Brief: